论文部分内容阅读
目的:分析长江流域6城市2008年抗真菌药物的使用情况。方法:采用金额和用药频度分析及排序法进行药物利用分析。结果:2008年6城市抗真菌药物用药总金额为3.04亿元。通用名金额排名前三的基本上都是三唑类药物,氟康唑居首位。商品名金额排名前两位的是大扶康和斯皮仁诺注射液,DDDs通用名前两位的是伊曲康唑与特比萘芬,商品名排名各市差异较大。厂商金额排名前两位的是辉瑞公司及西安杨森公司,药品构成以进口及合资为主。结论:系统性抗真菌药物使用广泛,尤其是氟康唑及伊曲康唑,浅表真菌感染趋于使用特比萘芬,棘白菌素类药物使用增长最为显著。进口药及合资药占据了主要市场,国产药市场较2007年略有增加。
Objective: To analyze the use of antifungal drugs in 6 cities in the Yangtze River Basin in 2008. Methods: The use of the amount and frequency of drug analysis and sequencing analysis of drug use. Results: In 2008, the total amount of antifungal drug used in 6 cities was 304 million yuan. Top three generic names are basically triazole drugs, fluconazole topped the list. Top two names in the name of the goods are Topix and Sporanox injection, DDDs generic top two are itraconazole and terbinafine, the names of cities vary greatly. Top two manufacturers in the amount of Pfizer and Xi’an Yang Sen company, the composition of the main drug imports and joint ventures. CONCLUSIONS: The use of systemic antifungal agents is widespread, especially fluconazole and itraconazole. Topical fungal infections tended to use terbinafine, with the most significant increase being in the use of echinocandins. Imported drugs and joint-stock drugs dominated the market, with the domestically produced drug market slightly up from 2007.